Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02712853 · ClinicalTrials.gov registry record
Improving Autism Screening With Brain-Related miRNA
A clinical trial of Autism Spectrum Disorder and Developmental Delay, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- 304
- Enrollment target
- 1
- Study location
NCT02712853: Completed study of Autism Spectrum Disorder and Developmental Delay, sponsored by Milton S. Hershey Medical Center.
NCT02712853 is a study of Autism Spectrum Disorder and Developmental Delay that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 304 participants, above the 134-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (127% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02712853, a study of Autism Spectrum Disorder and Developmental Delay, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- 304 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this project is to identify specific miRNAs that are increased or decreased in the saliva of children with developmental delay and are useful for screening toddlers for ASD. Such a screening tool would improve the specificity of diagnosis, streamline referrals to developmental specialists, and expedite the arrangement of early intervention services.
Primary Outcome
Measures of miRNA abundance in saliva
Conditions Studied
Interventions
- OTHER Saliva collection
- OTHER Vineland Adaptive Behavior Scale-II Assessment
Study Locations (1)
Pennsylvania
- Penn State Milton S. Hershey Medical Center - Hershey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 304 participants |
| Start Date | 2015-11 |
| Est. Completion | 2018-08 |
What the finished NCT02712853 record still lists
NCT02712853 is an observational study that tracks outcomes without assigning an intervention. The registered 304 participants enrollment target is mid-sized for trials with a published cap, above the 134-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (127% higher).
The record links to 2 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 2 interventions - of which Saliva collection is the first listed.
NCT02712853 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02712853 about?
NCT02712853 is a clinical study titled "Improving Autism Screening With Brain-Related miRNA". The goal of this project is to identify specific miRNAs that are increased or decreased in the saliva of children with developmental delay and are useful for screening toddlers for ASD. Such a screening tool would improve the specificity of diagnosis, streamline referrals to developmental specialist...
What is the current status of trial NCT02712853?
This trial is currently completed. The enrollment target is 304 participants. The study started on 2015-11. Estimated completion is 2018-08.
What conditions does trial NCT02712853 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder, Developmental Delay.
What interventions are being tested in trial NCT02712853?
The interventions under investigation include: Saliva collection (OTHER), Vineland Adaptive Behavior Scale-II Assessment (OTHER).
Who is sponsoring clinical trial NCT02712853?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02712853 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02712853's enrollment target sits among peer trials
304 26th of 224 higher than 199 of 224 other Autism Spectrum Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of an 8-Week Pickleball Program for Adults With Autism: A Feasibility Trial With a Delayed-Control Design
RECRUITING · Early Phase 1
-
Cannabidiol (CBD) in Adults With ASD
RECRUITING · Phase 1
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder
RECRUITING · Phase 2
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04750616 · 304 participants · Phase 2
NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial
- NCT04994717 · 304 participants · Phase 3
Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia
- NCT06036147 · 304 participants · NA
Concussion Health Improvement Program
- NCT06096844 · 304 participants · Phase 3
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia